Keywords: لوسمی میلوئید حاد (AML); Extracellular matrix (ECM); Acute myeloid leukemia (AML); Hematopoiesis; Clinical study; PCR;
مقالات ISI لوسمی میلوئید حاد (AML) (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: لوسمی میلوئید حاد (AML); 7â+â3; cytarabine 7 days and daunorubicin (3 days); AE; adverse event; alloHSCT; allogeneic hematopoietic stem cell transplant; AML; acute myeloid leukemia; AML-MRC; AML with myelodysplasia-related changes; AR; allelic ratio; BSC; best supportive care
Keywords: لوسمی میلوئید حاد (AML); Haploidentical stem cell transplant; Post-transplant cyclophosphamide; Elderly patients; Acute myeloid leukemia (AML); Myelodysplastic syndrome (MDS);
Keywords: لوسمی میلوئید حاد (AML); Aminopeptidases; Puromycin-sensitive aminopeptidase (PSA); Aminopeptidase N (APN); Amino acid deprivation response (AADR); Acute myeloid leukemia (AML); Acute lymphoblastic leukemia (ALL);
Keywords: لوسمی میلوئید حاد (AML); Essential thrombocythemia (ET); Transformation; Myelofibrosis; Myelodysplastic syndromes (MDS); Acute myeloid leukemia (AML); Prognostic factors
Keywords: لوسمی میلوئید حاد (AML); Acute lymphoblastic leukemia (ALL); Acute myeloid leukemia (AML); Thymidine kinase 1 (TK1); Deoxythymidine triphosphate (dTTP); Reference values (RVs);
Keywords: لوسمی میلوئید حاد (AML); Acute myeloid leukemia (AML); Central nerve system (CNS); Hematopoietic cell transplantation (HCT)
Keywords: لوسمی میلوئید حاد (AML); Microtubules; Chemotherapy; Resistance; Acute myeloid leukemia (AML); P-glycoprotein
Keywords: لوسمی میلوئید حاد (AML); Clofarabine; Adults; Acute myeloid leukemia (AML)
Keywords: لوسمی میلوئید حاد (AML); Acute myeloid leukemia (AML); CD117 biomarker; Aptamer-drug conjugates; Methotrexate (MTX); Oligonucleotide aptamer; Targeted therapy;
Keywords: لوسمی میلوئید حاد (AML); Minimal residual disease (MRD); Flow cytometry; Acute lymphoblastic leukemia (ALL); Acute myeloid leukemia (AML)
High bone marrow miR-19b level predicts poor prognosis and disease recurrence in de novo acute myeloid leukemia
Keywords: لوسمی میلوئید حاد (AML); AML; acute myeloid leukemia; BM; bone marrow; CR; complete remission; FAB; French-American-British; HRMA; high-resolution melting analysis; RQ-PCR; real-time quantitative PCR; ROC; receiver operating characteristic; AUC; area under the ROC curve; OS; over
The cytokine network in acute myeloid leukemia (AML): A focus on pro- and anti-inflammatory mediators
Keywords: لوسمی میلوئید حاد (AML); Acute myeloid leukemia (AML); IL-1β; IL-6; IL-1Ra; TGFβ; IL-10; IL-35;
Immunotherapy for acute myeloid leukemia (AML): a potent alternative therapy
Keywords: لوسمی میلوئید حاد (AML); AML; acute myeloid leukemia; GO; gemtuzumab ozogamacin; PBD; pyrrolobenzodiazepine; HuM196; humanized murine 196; CARs; chimeric antigen receptors; LAA; leukemia associated antigens; TCRT; cell receptor; NKG2D; natural killer group 2 D; MHC; major histoco
Dual inhibition of PI3K/mTOR signaling in chemoresistant AML primary cells
Keywords: لوسمی میلوئید حاد (AML); PI3K/AKT/mTOR inhibitors; Drug resistance; Acute myeloid leukemia (AML); Etoposide/Cytarabine;
Antileukemic effect of paclitaxel in combination with metformin in HL-60 cell line
Keywords: لوسمی میلوئید حاد (AML); APL; acute promyelocytic leukemia; AML; acute myeloid leukemia; PML/RARα; promyelocytic leukemia/retinoic acid receptor α; ATRA; all-trans retinoic acid; ATO; arsenic trioxide; T2DM; Type 2 Diabetes Mellitus; mTORC1; rapamycin complex 1; AMPK; AMP-activ
When the good go bad: Mutant NPM1 in acute myeloid leukemia
Keywords: لوسمی میلوئید حاد (AML); Acute myeloid leukemia (AML); differentiation; NPM1c+; gain-of-function, apoptosis; nuclear export signal (NES);
Identification of pyrrolo[2,3-d]pyrimidines as potent HCK and FLT3-ITD dual inhibitors
Keywords: لوسمی میلوئید حاد (AML); Acute myeloid leukemia (AML); FMS-like tyrosine kinase 3 with internal tandem duplication mutations (FLT3-ITD); Hematopoietic cell kinase (HCK); Pyrrolo[2,3-d]pyrimidine;
Research paperEstablishment of cell line with NK/NKT phenotype from myeloid NK cell acute leukemia
Keywords: لوسمی میلوئید حاد (AML); Acute myeloid leukemia (AML); Cell line; Karyotyping; NK/NKT phenotype; Cytoxicity;
Synthetic strategy for increasing solubility of potential FLT3 inhibitor thieno[2,3-d]pyrimidine derivatives through structural modifications at the C2 and C6 positions
Keywords: لوسمی میلوئید حاد (AML); FLT3; Thieno[2,3-d]pyrimidine; Acute myeloid leukemia (AML); Solubility;
A segmentation method based on HMRF for the aided diagnosis of acute myeloid leukemia
Keywords: لوسمی میلوئید حاد (AML); Cell segmentation; Acute myeloid leukemia (AML); Blast; Expectation Maximization (EM); K-means; HMRF;
Design, synthesis and biological evaluation of indolin-2-one-based derivatives as potent, selective and efficacious inhibitors of FMS-like tyrosine kinase3 (FLT3)
Keywords: لوسمی میلوئید حاد (AML); Indolin-2-one derivatives; FLT3 inhibitors; Structure-activity relationships (SARs); Acute myeloid leukemia (AML); In vivo study;
Design, synthesis and evaluation of anti-CD123 antibody drug conjugates
Keywords: لوسمی میلوئید حاد (AML); CD123; Camptothecin; Acute myeloid leukemia (AML); Leukemia stem cells (LSCs); Antibody drug conjugates (ADCs); AML; acute myeloid leukemia; LSCs; leukemia stem cells; ADCs; antibody drug conjugates; CPT; Camptothecin; GSH; Glutathione;
Auger electron-emitting 111In-DTPA-NLS-CSL360 radioimmunoconjugates are cytotoxic to human acute myeloid leukemia (AML) cells displaying the CD123+/CD131â phenotype of leukemia stem cells
Keywords: لوسمی میلوئید حاد (AML); Acute myeloid leukemia (AML); Radioimmunotherapy; Indium-111; CD123; Auger electrons; Nuclear translocation sequences (NLS);
ReviewEnhancement of arabinocytosine (AraC) toxicity to AML cells by a differentiation agent combination
Keywords: لوسمی میلوئید حاد (AML); Vitamin D analog; AraC; Plant antioxidant; Acute myeloid leukemia (AML); Apoptosis; VDR; Chk1;
Acquired expression of osteopontin selectively promotes enrichment of leukemia stem cells through AKT/mTOR/PTEN/β-catenin pathways in AML cells
Keywords: لوسمی میلوئید حاد (AML); Curcumin; Osteopontin; Leukemic Stem Cell; Acute myeloid leukemia (AML); KG-1; U937 cells
Novel anticancer compound [trifluoromethyl-substituted pyrazole N-nucleoside] inhibits FLT3 activity to induce differentiation in acute myeloid leukemia cells
Keywords: لوسمی میلوئید حاد (AML); Heterocyclic compound; Trifluoromethyl-substituted pyrazole N-nucleosides; Anticancer; Acute myeloid leukemia (AML); Cell differentiation; FLT3; G-11; [1-(2â³,3â³,4”,6â³-Tetra-O-acetyl-β-D-glucopyranosyl)-4-(3â²-trifluoromethylphenyl hydrazono)-3-t
A novel TCR-like CAR with specificity for PR1/HLA-A2 effectively targets myeloid leukemia in vitro when expressed in human adult peripheral blood and cord blood T cells
Keywords: لوسمی میلوئید حاد (AML); acute myeloid leukemia (AML); CAR-T cell; h8F4; PR1; UCB;
Overexpression of CD158 and NKG2A Inhibitory Receptors and Underexpression of NKG2D and NKp46 Activating Receptors on NK Cells in Acute Myeloid Leukemia
Keywords: لوسمی میلوئید حاد (AML); NK cells; NK cell receptors; Killer cell immunoglobulin-like receptors (KIRs); Natural cytotoxicity receptors (NCRs); Acute myeloid leukemia (AML)
Whole-arm translocation of der(5;17)(p10;q10) with concurrent TP53 mutations in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS): A unique molecular-cytogenetic subgroup
Keywords: لوسمی میلوئید حاد (AML); Der(5;17); complex karyotypes; TP53; acute myeloid leukemia (AML); myelodysplastic syndrome (MDS)
Structural modifications at the 6-position of thieno[2,3-d]pyrimidines and their effects on potency at FLT3 for treatment of acute myeloid leukemia
Keywords: لوسمی میلوئید حاد (AML); Fms-like tyrosine kinase 3 (FLT3); Acute myeloid leukemia (AML); Thieno[2,3-d]pyrimidine; Metabolic stability;
Targeting CXCR4/SDF-1 axis by lipopolymer complexes of siRNA in acute myeloid leukemia
Keywords: لوسمی میلوئید حاد (AML); Gene expression; CXCR4; SDF-1 (CXCL12); RNAi; SiRNA; Gene therapy; Acute myeloid leukemia (AML); THP-1; Bone marrow stromal cell attachment; Cell adhesion; Cell proliferation; Lipopolymer; Non-viral delivery; Co-culture; Drug delivery; Lipid;
Discovery of 6-phenylimidazo[2,1-b]thiazole derivatives as a new type of FLT3 inhibitors
Keywords: لوسمی میلوئید حاد (AML); 6-Phenylimidazo[2,1-b]thiazole; Acute myeloid leukemia (AML); FLT3; FLT3-ITD; MV4-11; Anti-viability;
A cryptic three-way translocation t(10;19;11)(p12.31;q13.31;q23.3) with a derivative Y-chromosome in an infant with acute myeloblastic leukemia (M5b)
Keywords: لوسمی میلوئید حاد (AML); AL; acute leukemia; aMCB; array-proven multicolor-banding; ALL; acute lymphatic leukemia; AML; acute myeloid leukemia; ANAE; alpha-naphthyl-acetate-esterase; BAC; bacterial artificial chromosome; BM; bone marrow; DAPI; Diaminophenylindol; FISH; fluorescen
Finding the optimal combination therapy for the treatment of newly diagnosed AML in older patients unfit for intensive therapy
Keywords: لوسمی میلوئید حاد (AML); Acute myeloid leukemia (AML); Combination; Low-intensity; Newly diagnosed; Novel agents; Older/elderly;
The molecular signature of AML mesenchymal stromal cells reveals candidate genes related to the leukemogenic process
Keywords: لوسمی میلوئید حاد (AML); Acute myeloid leukemia (AML); Human mesenchymal stromal cells (hMSCs); Molecular signature;
Deletion and deletion/insertion mutations in the juxtamembrane domain of the FLT3 gene in adult acute myeloid leukemia
Keywords: لوسمی میلوئید حاد (AML); FLT3; Juxtamembrane domain; Deletion/insertion; Mutation; Acute myeloid leukemia (AML);
An exploratory phase 2 study of investigational Aurora A kinase inhibitor alisertib (MLN8237) in acute myelogenous leukemia and myelodysplastic syndromes
Keywords: لوسمی میلوئید حاد (AML); Aurora A kinase inhibitor; Alisertib; Safety; Acute myeloid leukemia (AML); Myelodysplastic syndrome (MDS);
ERK 5/MAPK pathway has a major role in 1α,25-(OH)2 vitamin D3-induced terminal differentiation of myeloid leukemia cells
Keywords: لوسمی میلوئید حاد (AML); 1,25D; 1α,25(OH)2 vitamin D3; AML; acute myeloid leukemia; CC; cell cycle; VDD; vitamin D derivative; BIX; BIX02189; PD; PD98059; U0; U0126; XMD; XMD8-92; Vitamin D derivatives; ERK5; ERK1/2; MAPK inhibitors; Acute myeloid leukemia (AML); Cell differenti
Attenuated A20 expression of acute myeloid leukemia-derived dendritic cells increased the anti-leukemia immune response of autologous cytolytic T cells
Keywords: لوسمی میلوئید حاد (AML); Minimal residual disease (MRD); Acute myeloid leukemia (AML); Zinc finger protein A20; AML-derived DCs (AML-DCs);
Synthesis and biological evaluation of novel thieno[2,3-d]pyrimidine-based FLT3 inhibitors as anti-leukemic agents
Keywords: لوسمی میلوئید حاد (AML); FMS-like tyrosine kinase 3 (FLT3); Acute myeloid leukemia (AML); Thieno[2,3-d]pyrimidine; Internal tandem duplications (ITD); D835YHFJLFYNATMPMFX-UHFFFAOYSA-N; GVKJRDNBYFNJKE-UHFFFAOYSA-N; AUUTWZCOPWHSTH-UHFFFAOYSA-N; CKDGYWGTEHFGDW-UHFFFAOYSA-N; RQQGAGUN
Allogeneic Hematopoietic Cell Transplantation in First Remission Abrogates Poor Outcomes Associated with High-Risk Pediatric Acute Myeloid Leukemia
Keywords: لوسمی میلوئید حاد (AML); Acute myeloid leukemia (AML); High-risk; Transplantation pediatric
Inhibition of the miR-143/145 cluster attenuated neutrophil differentiation of APL cells
Keywords: لوسمی میلوئید حاد (AML); miR-145; Acute myeloid leukemia (AML); Acute promyelocytic leukemia (APL); p73; Neutrophil;
Determination of cellular uptake and intracellular levels of Cenersen (Aezea®, EL625), a p53 antisense oligonucleotide in acute myeloid leukemia cells
Keywords: لوسمی میلوئید حاد (AML); Cenersen; p53 antisense; Acute myeloid leukemia (AML); Enzyme-linked immunosorbent assay (ELISA); Intracellular uptakeAML, acute myeloid leukemia; AP, alkaline phosphatase; CV, coefficient of variation; ELISA, enzyme-linked immunosorbent assay; LOQ, lower
Is it time to revisit standard post-remission therapy?
Keywords: لوسمی میلوئید حاد (AML); acute myeloid leukemia (AML); maintenance; post-remission; risk-adapted; standard therapy; transplant;
High Response Rate for Treatment With Gemtuzumab Ozogamicin and Cytarabine in Elderly Patients With Acute Myeloid Leukemia and Favorable and Intermediate-I Cytogenetic Risk
Keywords: لوسمی میلوئید حاد (AML); Acute myeloid leukemia (AML); Cytogenetic analysis; Elderly; Gemtuzumab ozogamicin
Synergistic effect of Toll-like receptor 4 and 7/8 agonists is necessary to generate potent blast-derived dendritic cells in Acute Myeloid Leukemia
Keywords: لوسمی میلوئید حاد (AML); Acute Myeloid Leukemia (AML); Dendritic cell; TLR agonists
Topotecan exposure estimation in pediatric acute myeloid leukemia supported by LC-MS-based drug monitoring and pharmacokinetic analysis
Keywords: لوسمی میلوئید حاد (AML); Topotecan; Acute myeloid leukemia (AML); Pediatrics; Liquid chromatography coupled to mass spectrometry (LC-MS); Pharmacokinetic analysis;
Acute myeloid leukemia: A central role for the ETS factor ERG
Keywords: لوسمی میلوئید حاد (AML); ERG; Acute myeloid leukemia (AML); ETS-factor; Hematopoiesis
Biologic activity of triptolide in t(8;21) acute myeloid leukemia cells
Keywords: لوسمی میلوئید حاد (AML); Triptolide; Acute myeloid leukemia (AML); t(8 ;21); AML1-ETO; C-KIT; JAK-STAT; NF-κB